Loading clinical trials...
Loading clinical trials...
Design and Evaluation of a Novel Methodology for Stereotactic Ablative Radiotherapy for Lung Cancer: Reducing Treatment Side-effects and Enabling More Patients to Benefit From This Treatment
Conditions
Start Date
July 1, 2021
Primary Completion Date
June 1, 2023
Completion Date
December 1, 2023
Last Updated
June 16, 2021
NCT06066138
NCT05198830
NCT07336732
NCT07486219
NCT06498635
NCT07485114
Lead Sponsor
Royal Surrey County Hospital NHS Foundation Trust
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions